Sort   by:  
 Page size 
ProteomicsUCHL1 is a Molecular Indicator and a Therapeutic Target for Neuroendocrine Carcinomas
Quantitative proteomics analysis was performed on patient derived neuroendocrine tissue xenografts comparing sh control (N=2), and shUCHL1 (N=4), and in NCI-H660 cell line xenografts comparing control (N=3) and LDN-57444 treated (N=3). Each condition was injected in triplicate.
ORGANISM(S): Mus musculus (Mouse) Homo sapiens (Human) 
2023-12-03 | PXD044864 | Pride
Uchl1 Xenografts Prostate cancer Neuroendocrine carcinomas 
UnknownUCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
Not available
S-EPMC10897521 | biostudies-literature
UnknownSystemic and mucosal differences in HIV burden, immune, and therapeutic responses.
Not available
S-EPMC3164950 | biostudies-literature
UnknownImmune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
Not available
S-EPMC8366808 | biostudies-literature
UnknownSARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Not available
S-EPMC11117088 | biostudies-literature
UnknownRisk of COVID-19 after natural infection or vaccination.
Not available
S-EPMC10518569 | biostudies-literature
UnknownClinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Not available
S-EPMC10346130 | biostudies-literature
UnknownEfficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692 | biostudies-literature
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219 | biostudies-literature
Sort   by:  
 Page size